301 related articles for article (PubMed ID: 11184249)
21. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
Kurth AA; Ludwig G; Scharrer I
Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
23. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].
Guermazi S; Conard J; Samama MM; Dellagi K
Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858
[TBL] [Abstract][Full Text] [Related]
24. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
25. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
Favaloro EJ
Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
[TBL] [Abstract][Full Text] [Related]
26. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
Penas N; Pérez-Rodríguez A; Torea JH; Lourés E; Noya MS; López-Fernández MF; Batlle J
Am J Hematol; 2005 Nov; 80(3):188-96. PubMed ID: 16247740
[TBL] [Abstract][Full Text] [Related]
27. The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects.
Marcus PD; Nire KG; Grooms L; Klima J; O'Brien SH
Haemophilia; 2011 Mar; 17(2):223-7. PubMed ID: 20860605
[TBL] [Abstract][Full Text] [Related]
28. Capillary microscopic and rheological dimensions for the diagnosis of von Willebrand disease in comparison to other haemorrhagic diatheses.
Koscielny JK; Latza R; Mürsdorf S; Mrowietz C; Kiesewetter H; Wenzel E; Jung F
Thromb Haemost; 2000 Dec; 84(6):981-8. PubMed ID: 11154145
[TBL] [Abstract][Full Text] [Related]
29. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand disease: a laboratory approach.
Trasi S; Ghosh K; Shetty S; Mohanty D
Natl Med J India; 2005; 18(2):78-84. PubMed ID: 15981443
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test.
Pareti FI; Cattaneo M; Carpinelli L; Zighetti ML; Bressi C; Mannucci PM; Ruggeri ZM
Thromb Haemost; 1996 Sep; 76(3):460-8. PubMed ID: 8883287
[TBL] [Abstract][Full Text] [Related]
32. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
33. Clinical diagnosis of von Willebrand disease.
Federici AB
Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
Favaloro EJ
Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
[TBL] [Abstract][Full Text] [Related]
35. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
[TBL] [Abstract][Full Text] [Related]
36. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
37. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
[TBL] [Abstract][Full Text] [Related]
38. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
39. Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems.
Favaloro EJ; Henniker A; Facey D; Hertzberg M
Thromb Haemost; 2000 Oct; 84(4):541-7. PubMed ID: 11057847
[TBL] [Abstract][Full Text] [Related]
40. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
Favaloro EJ
Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
